Ken Inchausti
Outgoing Director, R&D and Global Medical Communications
Bio:
Ken Inchausti is an experienced life sciences communications executive with more than 30 years of expertise spanning the pharmaceutical, biotech, consulting, hospital, and non-profit sectors. He has led corporate and R&D communications, executive engagement, and reputation strategies for companies including Novo Nordisk, Ocugen, GlaxoSmithKline, and ViiV Healthcare.
Ken’s experiences include shaping corporate responses to high-profile healthcare issues such as insulin pricing, guiding scientific and product launch communications in areas from oncology to vaccines, and building public–private partnerships to address health equity. He has also worked on the agency side, counseling clients at Fleishman Hillard and other leading firms, and held leadership roles at the American Diabetes Association and Premier, Inc.
With a focus on making science accessible, fostering trust, and driving meaningful change, Ken brings a unique perspective on how communications can enable innovation in healthcare. He lives in Philadelphia, PA.